Payal Rabde, a Healthcare Industry Expert, highlights that the genetic disease diagnostic market has reached USD 12.62 billion in 2026 to USD 22.64 billion by 2035, growing at a CAGR of 13.71%, Key genetic disease diagnostic market companies shaping the market include Illumina Myriad Genetics, Labcorp (incl. Invitae) while major growth segments span application, Product, technology, end user, region.